IGC Pharma, Inc.IGCNYSE
Loading
Year-over-year total asset growth rate
Latest
-0.32%
↓ 146% vs avg
Percentile
P69
Within normal range
Streak
1 qtr
Consecutive declineDecelerating
Average
0.69%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | -0.32% |
| Q3 2025 | 22.66% |
| Q2 2025 | -9.19% |
| Q1 2025 | -3.65% |
| Q4 2024 | -12.45% |
| Q3 2024 | -2.12% |
| Q2 2024 | 6.99% |
| Q1 2024 | -12.05% |
| Q4 2023 | -31.79% |
| Q3 2023 | 5.31% |
| Q2 2023 | -8.76% |
| Q1 2023 | -14.41% |
| Q4 2022 | -8.60% |
| Q3 2022 | -9.14% |
| Q2 2022 | -9.94% |
| Q1 2022 | -14.24% |
| Q4 2021 | -7.53% |
| Q3 2021 | -1.77% |
| Q2 2021 | -3.97% |
| Q1 2021 | 48.44% |
| Q4 2020 | -8.29% |
| Q3 2020 | -6.90% |
| Q2 2020 | -2.36% |
| Q1 2020 | -6.81% |
| Q4 2019 | -5.43% |
| Q3 2019 | -1.84% |
| Q2 2019 | -2.79% |
| Q1 2019 | -7.25% |
| Q4 2018 | 124.53% |
| Q3 2018 | 43.71% |
| Q2 2018 | 6.11% |
| Q1 2018 | -4.26% |
| Q4 2017 | 13.45% |
| Q3 2017 | 5.89% |
| Q2 2017 | -16.38% |
| Q1 2017 | 1.02% |
| Q4 2016 | -40.77% |
| Q3 2016 | 1.97% |
| Q2 2016 | -1.93% |
| Q1 2016 | 2.48% |